Investors

In this section of the Rock Creek Pharmaceuticals Investor pages, you'll find our news releases. The releases are listed in chronological order and are archived by year.

Archives: Search / 2016 / 2015 / 2014

2014 Archives

Dec 23, 2014
Provides European Drug Development Strategy Update

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced today that it has filed a Clinical Trial Application (CTA) with the United Kingdom's Medicines Healthcare products Regulatory Agency...

More
Dec 11, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today that it received notification from...

More
Nov 21, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company is scheduled to present at the Biotech Showcase™ 2015 taking place in San Francisco, CA on January 12-14, 2015....

More
Nov 10, 2014

Rock Creek Pharmaceuticals, Inc., (RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today its financial results for the third quarter ended

More
Oct 23, 2014
Four Preclinical Study Abstracts Evaluate Anatabine Across Neurological Disorders

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today that abstracts outlining four separate...

More
Sep 12, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today it has received a written response...

More
Aug 11, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today that it filed with the Securities...

More
Aug 6, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company has made two key independent appointments to the Company's Board of Directors with the recent election of Ms. Lee M....

More
Aug 4, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company has been selected to present at the Next Generation Track at BioPharm America 2014 in Boston (Sept. 22-24, 2014) at The...

More
Jul 31, 2014

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced today that it has initiated the development of its lead molecule, Anatabine Citrate, in Europe; and that it has selected Quotient...

More
Jul 11, 2014

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI), an emerging biotechnology company, today announced that the Food and Drug Administration ("FDA"), has notified the Company that the agency will...

More
Jun 2, 2014

Star Scientific, Inc. (NASDAQ: STSI) announced that the Company will formally change its corporate name to Rock Creek Pharmaceuticals, Inc. effective June 4, 2014, with a new ticker symbol of...

More
Apr 30, 2014

Star Scientific, Inc., (NASDAQ: STSI) announced that the Company has retained Shareholder Intelligence Services, LLC ("ShareIntel"), a provider of stock surveillance services and applications, to...

More
Mar 17, 2014

Star Scientific, Inc. (NASDAQ: STSI) today filed its annual report on Form 10-K with the Securities & Exchange Commission (SEC). In December 2013,...

More
Feb 14, 2014

Star Scientific, Inc., (NASDAQ: STSI) today announced that the Company will host an Analyst and Investor meeting for research analysts, and...

More
Feb 12, 2014

Star Scientific, Inc., (NASDAQ: STSI) announced today that Theodore Jenkins has joined the Company as Vice President, Corporate Strategy and...

More
Jan 10, 2014

Star Scientific, Inc., (NASDAQ: STSI) announced today that its conference call presentation announced on January 2, 2014, will be held at 4 p.m. ET...

More
Jan 2, 2014

Star Scientific, Inc., (NASDAQ: STSI) announced today that the Company will hold a conference call for investors on January 15, 2014, to discuss...

More
 

print email rss